SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient CarePRNewsWire • 05/30/24
Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a BetZacks Investment Research • 05/07/24
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 04/30/24
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024GlobeNewsWire • 04/23/24
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaPRNewsWire • 04/23/24
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)PRNewsWire • 04/17/24
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in CanadaPRNewsWire • 03/20/24
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear CollaborationPRNewsWire • 03/15/24
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare ConferenceGlobeNewsWire • 03/07/24
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care ConferenceGlobeNewsWire • 02/22/24
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024GlobeNewsWire • 02/20/24
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainPRNewsWire • 02/07/24
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaPRNewsWire • 01/15/24
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare ConferencePRNewsWire • 01/10/24